Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Accumulated Expenses (2018 - 2025)

Outset Medical (OM) has disclosed Accumulated Expenses for 8 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 29.1% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, down 29.1% year-over-year, with the annual reading at $1.4 million for FY2025, 29.1% down from the prior year.
  • Accumulated Expenses for Q4 2025 was $1.4 million at Outset Medical, down from $10.9 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $23.3 million in Q2 2022, with the low at $164000.0 in Q1 2025.
  • Average Accumulated Expenses over 5 years is $6.5 million, with a median of $3.3 million recorded in 2021.
  • The sharpest move saw Accumulated Expenses skyrocketed 3208.82% in 2022, then plummeted 96.19% in 2024.
  • Over 5 years, Accumulated Expenses stood at $3.7 million in 2021, then plummeted by 75.49% to $908000.0 in 2022, then skyrocketed by 1993.06% to $19.0 million in 2023, then crashed by 89.8% to $1.9 million in 2024, then dropped by 29.1% to $1.4 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $1.4 million, $10.9 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.